SLU-PP-332 5mg research peptide vial by FYH Peptides
COA Verified
Metabolic Research Cat№ FYH-013

SLU-PP-332

5mg • Powder
$68.16 USD / vial

Small-molecule pan-agonist of the Estrogen-Related Receptor (ERR-α / ERR-β / ERR-γ) family. Research-grade powder for in vitro receptor binding assay.

Technical Data

Catalog №
FYH-013
CAS №
Research compound (no public CAS)
Purity (HPLC)
99.93%
Mol. Weight
≈ 480 g/mol
Mass / Vial
5mg
Form
Powder
Tested Batch №
SLU-26SLU5-003
Storage
−20 °C, lyophilized
Origin
Switzerland, GMP-grade synthesis
Sequence / Structure
N/A — small-molecule ERR agonist

Certificate of Analysis

SLU-PP-332 5mg HPLC Certificate of Analysis — batch SLU-26SLU5-003 Click image to open full-resolution COA →
Add to Inquiry

💳 Card & crypto checkout is launching soon. For now, every order is arranged securely with our verified specialist on Telegram (@FYHPeptides).

Published Research

Peer-reviewed literature indexed on NCBI PubMed referencing SLU-PP-332. Listed for laboratory reference only — FYH Peptides makes no claim regarding the conclusions of any cited author. Click PubMed or DOI to read the original publication. Updated 2026-05-20.

  1. 1.
    A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
    Billon C, Schoepke E, Avdagic A, et al.
    The Journal of pharmacology and experimental therapeutics · 2024
    PubMed DOI 10.1124/jpet.123.001733 PMID: 37739806
  2. 2.
    FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    Wang XX, Wang D, Luo Y, et al.
    Journal of the American Society of Nephrology : JASN · 2018
    PubMed DOI 10.1681/ASN.2017020222 PMID: 29089371
  3. 3.
    Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
    Billon C, Sitaula S, Banerjee S, et al.
    ACS chemical biology · 2023
    PubMed DOI 10.1021/acschembio.2c00720 PMID: 36988910
  4. 4.
    ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress.
    Jung YS, Radhakrishnan K, Hammad S, et al.
    Redox biology · 2024
    PubMed DOI 10.1016/j.redox.2024.103107 PMID: 38479224
  5. 5.
    PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression.
    Antwi MB, Lefere S, Clarisse D, et al.
    Metabolism: clinical and experimental · 2025
    PubMed DOI 10.1016/j.metabol.2024.156128 PMID: 39743041
  6. 6.
    APOE2 protects against Aβ pathology by improving neuronal mitochondrial function through ERRα signaling.
    Ning Z, Liu Y, Wan M, et al.
    Cellular & molecular biology letters · 2024
    PubMed DOI 10.1186/s11658-024-00600-x PMID: 38867189
  7. 7.
    Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.
    Wang XX, Myakala K, Libby AE, et al.
    The American journal of pathology · 2023
    PubMed DOI 10.1016/j.ajpath.2023.07.008 PMID: 37717940
  8. 8.
    An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
    Billon C, Appourchaux K, Côté I, et al.
    The Journal of pharmacology and experimental therapeutics · 2026
    PubMed DOI 10.1016/j.jpet.2025.103787 PMID: 41421047
⚠️ For Research Use Only. This product is sold exclusively for in vitro laboratory research use by qualified researchers and laboratories. It is NOT intended for human consumption, medical use, or as a dietary supplement. The FDA has not evaluated this product for safety or efficacy.

Related research compounds

More compounds researchers browse alongside SLU-PP-332.

Retatrutide 10mg research peptide 99.45%
Metabolic Research Retatrutide 10mg $139.92
MOTS-C 10mg research peptide 99.92%
Metabolic Research MOTS-C 10mg $68.16
Tirzepatide 10mg research peptide 99.93%
Metabolic Research Tirzepatide 10mg $125.57
5-Amino-1mq 10mg research peptide 99.93%
Metabolic Research 5-Amino-1mq 10mg $68.16
View full catalog →
$68.16 USD / vial
Add to Inquiry